Company
Thryv
Claim, correct or request removal
Record updated 20 September 2026
About
Thryv has a first-in-class treatment for a rare pediatric cardiology disease called Long QT Syndrome that demonstrated strong efficacy signal in its Phase 2a study.
Loading relationship preview